Griffon Corporation
GFF · NYSE
Analyst ratings
strong_buy · 1 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| February 9, 2026 | Stephens & Co. | Maintains | Overweight | $115.00 |
| November 24, 2025 | Stephens & Co. | Maintains | Overweight | $92.00 |
Revenue trajectory and end-market demand outlook
Griffon anticipates $1.8 billion in revenue for fiscal 2026 with an adjusted EBITDA of $458 million, suggesting the company can maintain profitability even amid top-line pressures. Recent quarterly results beat expectations, with revenue of $421.86 million surpassing the $414.63 million consensus estimate.
Griffon faces severe structural demand headwinds, with sales declining 3.1% annually over the last five years and a projected revenue drop of 14.2% over the next 12 months. Year-over-year quarterly revenue was down 31%, signaling persistent deterioration across its home improvement and building products end markets.
Earnings growth potential versus declining EPS trend
Griffon beat the quarterly EPS consensus of $0.99 by posting $1.05, and the full-year Zacks consensus estimates $5.17 in EPS for the current fiscal year. Robert W. Baird maintained a $115 price target, reflecting confidence that profitability can hold despite revenue contraction.
EPS is forecast to decline 8.5% for the full year, and quarterly EPS fell from $1.23 to $1.05 year over year. Earnings growth has underperformed the sector average over the last two years, with EPS growing just 6.3% annually, raising doubts about Griffon's ability to compound shareholder value.
Valuation premium and analyst conviction
Analysts maintain a Moderate Buy consensus with an average price target of $115, representing meaningful upside from the stock's recent price near $92.74. Institutional interest has grown, with the Louisiana State Employees Retirement System initiating a new position, signaling confidence in Griffon's long-term value.
Griffon trades at a forward P/E of 17.1x–18.65x, a significant premium to its industry average of 12.07x, which analysts at Wall Street Zen and Weiss Ratings find difficult to justify given declining revenues and slowing earnings growth. Multiple rating downgrades in mid-2025 reflect growing skepticism about the valuation.